In The News Posted January 7, 2020 Share Posted January 7, 2020 CARLSBAD, Calif., Jan. 7, 2020 /PRNewswire/ -- The neurological franchise of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, continued to shape the scientific and therapeutic landscape of the global biotechnology industry in 2019. By any metric, it was... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.